$CME

CME GROUP INC.

CIK:0001156375|SEC Filings

CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Thousands, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Revenues
Total Revenues	$ 1,706.2	$ 1,692.0	$ 3,586.3	$ 3,334.3
Expenses
Compensation and benefits	233.5	221.6	456.5	428.3
Technology	83.3	70.9	159.9	136.6
Professional fees and outside services	29.1	37.4	57.3	65.9
Amortization of purchased intangibles	56.0	56.1	112.1	111.3
Depreciation and amortization	28.2	27.3	55.4	54.6
Licensing and other fee agreements	109.1	96.2	215.9	192.8
Other	59.9	53.2	112.4	107.5
Total Expenses	599.1	562.7	1,169.5	1,097.0
Operating Income	1,107.1	1,129.3	2,416.8	2,237.3
Non-Operating Income (Expense)
Investment income	1,429.7	1,518.4	2,819.0	2,411.1
Interest and other borrowing costs	(43.6)	(44.0)	(87.2)	(85.7)
Equity in net earnings of unconsolidated subsidiaries	97.7	99.0	200.1	187.2
Other non-operating income (expense)	(1,263.2)	(1,372.4)	(2,510.1)	(2,174.8)
Total Non-Operating Income (Expense)	220.6	201.0	421.8	337.8
Income before Income Taxes	1,327.7	1,330.3	2,838.6	2,575.1
Income tax provision	285.9	305.2	642.5	593.8
Net Income	$ 1,041.8	$ 1,025.1	$ 2,196.1	$ 1,981.3
Earnings per Share Attributable to Common Shareholders of CME Group:
Basic (in dollars per share)	$ 2.89	$ 2.81	$ 6.11	$ 5.44
Diluted (in dollars per share)	$ 2.88	$ 2.81	$ 6.06	$ 5.43
Weighted Average Number of Common Shares:
Basic (in shares)	360,684	359,658	360,005	359,636
Diluted (in shares)	361,282	360,355	362,233	360,297
Clearing and transaction fees
Revenues
Total Revenues	$ 1,352.5	$ 1,388.0	$ 2,895.1	$ 2,725.3
Market data and information services
Revenues
Total Revenues	238.1	198.1	462.2	392.6
Other
Revenues
Total Revenues	$ 115.6	$ 105.9	$ 229.0	$ 216.4

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash Flows from Operating Activities
Net Income	$ 2,196.1	$ 1,981.3
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation	46.6	41.9
Amortization of purchased intangibles	112.1	111.3
Depreciation and amortization	55.4	54.6
Net realized and unrealized (gains) losses on investments	19.1	(2.6)
Deferred income taxes	(8.2)	(20.7)
Change in:
Accounts receivable	(112.9)	(95.4)
Other current assets	37.8	(24.6)
Other assets	(141.9)	29.8
Accounts payable	(3.8)	12.5
Income taxes payable	(40.4)	28.3
Other current liabilities	(49.4)	67.9
Other liabilities	113.4	(9.2)
Other	(16.9)	0.0
Net Cash Provided by Operating Activities	2,207.0	2,175.1
Cash Flows from Investing Activities
Proceeds from maturities of available-for-sale marketable securities	2.0	4.8
Purchases of available-for-sale marketable securities	(2.2)	(3.8)
Purchases of property, net	(45.4)	(32.6)
Investments in privately-held equity investments	(6.8)	(2.4)
Net Cash Used in Investing Activities	(52.4)	(34.0)
Cash Flows from Financing Activities
Proceeds from debt, net of issuance costs	0.0	742.3
Repayment of debt	0.0	(750.0)
Cash dividends	(3,165.7)	(3,022.7)
Repurchase of Class A common stock, including costs	(1,236.9)	(8.2)
Change in performance bond and guaranty fund contributions	(1,545.4)	43,262.5
Employee taxes paid on restricted stock vesting	(22.2)	(8.8)
Other	(4.6)	(4.5)
Net Cash (Used in) Provided by Financing Activities	(5,974.8)	40,210.6
Net change in cash, cash equivalents, restricted cash and restricted cash equivalents	(3,820.2)	42,351.7
Cash, cash equivalents, restricted cash and restricted cash equivalents, beginning of period	164,079.5	101,794.1
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, End of Period	160,259.3	144,145.8
Reconciliation of cash, cash equivalents, restricted cash and restricted cash equivalents:
Cash and cash equivalents	2,144.2	1,981.3
Short-term restricted cash	4.4	6.5
Restricted cash and restricted cash equivalents (performance bonds and guaranty fund contributions)	158,110.7	142,158.0
Total	160,259.3	144,145.8
Supplemental Disclosure of Cash Flow Information
Income taxes paid, net of refunds	689.7	579.6
Interest paid	$ 70.2	$ 65.0

CONSOLIDATED BALANCE SHEETS - USD ($) shares in Thousands, $ in Millions	Jun. 30, 2026	Dec. 31, 2025
Current Assets:
Cash and cash equivalents	$ 2,144.2	$ 4,416.9
Marketable securities	131.4	125.0
Accounts receivable, net of allowance of $9.1 and $10.0	753.1	639.2
Other current assets (includes $4.4 and $6.5 in restricted cash)	491.7	522.1
Performance bonds and guaranty fund contributions	158,110.7	159,656.1
Total current assets	161,631.1	165,359.3
Property, net of accumulated depreciation and amortization of $993.7 and $1,005.7	351.2	362.7
Intangible assets—trading products	17,175.3	17,175.3
Intangible assets—other, net	2,494.6	2,610.7
Goodwill	10,505.8	10,514.7
Other assets	2,518.6	2,401.5
Total Assets	194,676.6	198,424.2
Current Liabilities:
Accounts payable	68.0	71.8
Other current liabilities	538.6	568.8
Performance bonds and guaranty fund contributions	158,110.7	159,656.1
Total current liabilities	158,717.3	160,296.7
Long-term debt	3,424.2	3,422.3
Deferred income tax liabilities, net	5,220.9	5,242.2
Other liabilities	793.8	734.8
Total Liabilities	168,156.2	169,696.0
Shareholders' Equity:
Preferred stock, $0.01 par value, 10,000 shares authorized at June 30, 2026 and December 31, 2025; no shares issued and outstanding as of June 30, 2026 and 4,584 issued and outstanding as of December 31, 2025	0.0	0.0
Additional paid-in capital	21,004.4	22,209.5
Retained earnings	5,457.5	6,433.2
Accumulated other comprehensive income (loss)	54.9	81.9
Total CME Group Shareholders’ Equity	26,520.4	28,728.2
Total Liabilities and Equity	$ 194,676.6	$ 198,424.2
Preferred stock, shares outstanding (in shares)	0	4,584
Preferred stock, shares issued (in shares)	0	4,584
Common Class A
Shareholders' Equity:
Common stock	$ 3.6	$ 3.6
Common Class B
Shareholders' Equity:
Common stock	$ 0.0	$ 0.0